Palvella Therapeutics (PVLA) to Release Quarterly Earnings on Monday

Palvella Therapeutics (NASDAQ:PVLA) is anticipated to announce its earnings results before the market opens on Monday, March 31st. Analysts expect the company to announce earnings of ($0.39) per share for the quarter.

Palvella Therapeutics Stock Performance

PVLA stock opened at $28.10 on Friday. The firm has a market cap of $315.31 million, a price-to-earnings ratio of -2.32 and a beta of 0.54. Palvella Therapeutics has a 12-month low of $6.20 and a 12-month high of $29.27. The firm’s 50 day moving average price is $20.24.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on PVLA shares. Stifel Nicolaus started coverage on shares of Palvella Therapeutics in a research report on Wednesday. They set a “buy” rating and a $45.00 price objective for the company. TD Cowen started coverage on Palvella Therapeutics in a report on Wednesday, February 5th. They issued a “buy” rating and a $44.00 price target on the stock. HC Wainwright reissued a “buy” rating and set a $38.00 price target on shares of Palvella Therapeutics in a report on Tuesday, February 11th. Jones Trading assumed coverage on shares of Palvella Therapeutics in a research note on Tuesday. They issued a “buy” rating and a $45.00 price target on the stock. Finally, Cantor Fitzgerald started coverage on Palvella Therapeutics in a report on Wednesday, December 18th. They set an “overweight” rating on the stock. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Palvella Therapeutics currently has an average rating of “Buy” and an average price target of $43.50.

Palvella Therapeutics Company Profile

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc, formerly known as Pieris Pharmaceuticals Inc, is based in WAYNE, Pa.